Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, OH, USA.
Department of Internal Medicine, Mount Sinai Beth Israel, Icahn School of Medicine, NY, USA.
Am J Emerg Med. 2021 Dec;50:606-617. doi: 10.1016/j.ajem.2021.09.041. Epub 2021 Sep 21.
Identification of pulmonary embolism (PE) in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) carries significant therapeutic implications. We aimed to investigate the prevalence of PE in patients with AECOPD.
We searched MEDLINE, the Cochrane Central Register of Controlled Trials, and Embase. We registered the protocol at the PROSPERO (CRD42021230481). Two authors independently evaluated whether titles and abstracts met the eligibility criteria, which were as follows: (1), prospective study or cross-sectional study in case the protocol for workup of PE was specified in advance, (2) patients with AECOPD aged ≥ 18 years, and (3) investigated the prevalence of PE or venous thromboembolism (VTE). Two authors independently extracted the selected patient and study characteristics and outcomes. We presented the results of all analyses with the use of random-effects models. The primary outcome was the prevalence of PE.
We included 16 studies (N = 4093 patients) in this meta-analysis. The prevalence of PE in patients with AECOPD was 12% [95% confidence interval (CI), 9 to 16%]. Substantial heterogeneity was observed (I = 94.8%). The pooled mortality was higher in patients with PE than those without (odds ratio 5.30, 95%CI: 2.48-11.30, p-value < 0.001).
In this meta-analysis, the prevalence of PE in patients with AECOPD was 12% and the mortality of patients with PE was higher than those without. This suggests an acute necessity to develop validated diagnostic strategies for identifying PE in patients with AECOPD.
在慢性阻塞性肺疾病急性加重(AECOPD)患者中识别肺栓塞(PE)具有重要的治疗意义。我们旨在调查 AECOPD 患者中 PE 的患病率。
我们检索了 MEDLINE、Cochrane 对照试验中心注册库和 Embase。我们在 PROSPERO(CRD42021230481)上注册了该方案。两位作者独立评估了标题和摘要是否符合纳入标准,标准如下:(1)前瞻性研究或病例对照研究,如果事先指定了 PE 检查方案,(2)年龄≥18 岁的 AECOPD 患者,以及(3)调查 PE 或静脉血栓栓塞症(VTE)的患病率。两位作者独立提取选定的患者和研究特征及结局。我们使用随机效应模型呈现所有分析的结果。主要结局是 PE 的患病率。
我们在这项荟萃分析中纳入了 16 项研究(N=4093 例患者)。AECOPD 患者中 PE 的患病率为 12%[95%置信区间(CI):9%至 16%]。观察到明显的异质性(I=94.8%)。与无 PE 的患者相比,PE 患者的死亡率更高(比值比 5.30,95%CI:2.48-11.30,p 值<0.001)。
在这项荟萃分析中,AECOPD 患者中 PE 的患病率为 12%,PE 患者的死亡率高于无 PE 的患者。这表明迫切需要制定经过验证的诊断策略,以识别 AECOPD 患者中的 PE。